These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22410797)

  • 1. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.
    Geerdink LM; Westra D; van Wijk JA; Dorresteijn EM; Lilien MR; Davin JC; Kömhoff M; Van Hoeck K; van der Vlugt A; van den Heuvel LP; van de Kar NC
    Pediatr Nephrol; 2012 Aug; 27(8):1283-91. PubMed ID: 22410797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M; Caprioli J; Bresin E; Mossali C; Pianetti G; Gamba S; Daina E; Fenili C; Castelletti F; Sorosina A; Piras R; Donadelli R; Maranta R; van der Meer I; Conway EM; Zipfel PF; Goodship TH; Remuzzi G
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
    Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J; Janecke AR; Zimmerhackl LB; Riedl M; Rosales A; Giner T; Cortina G; Haindl CJ; Petzelberger B; Pawlik M; Jeller V; Vester U; Gadner B; van Husen M; Moritz ML; Würzner R; Jungraithmayr T;
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M; Zuber J; Moulin B; Kamar N; Jablonski M; Lionet A; Chatelet V; Mousson C; Mourad G; Bridoux F; Cassuto E; Loirat C; Rondeau E; Delahousse M; Frémeaux-Bacchi V
    Am J Transplant; 2013 Mar; 13(3):663-75. PubMed ID: 23356914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
    Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.
    Bienaime F; Dragon-Durey MA; Regnier CH; Nilsson SC; Kwan WH; Blouin J; Jablonski M; Renault N; Rameix-Welti MA; Loirat C; Sautés-Fridman C; Villoutreix BO; Blom AM; Fremeaux-Bacchi V
    Kidney Int; 2010 Feb; 77(4):339-49. PubMed ID: 20016463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
    Fan X; Yoshida Y; Honda S; Matsumoto M; Sawada Y; Hattori M; Hisanaga S; Hiwa R; Nakamura F; Tomomori M; Miyagawa S; Fujimaru R; Yamada H; Sawai T; Ikeda Y; Iwata N; Uemura O; Matsukuma E; Aizawa Y; Harada H; Wada H; Ishikawa E; Ashida A; Nangaku M; Miyata T; Fujimura Y
    Mol Immunol; 2013 Jun; 54(2):238-46. PubMed ID: 23314101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and complement in atypical HUS.
    Kavanagh D; Goodship T
    Pediatr Nephrol; 2010 Dec; 25(12):2431-42. PubMed ID: 20526633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. aHUS caused by complement dysregulation: new therapies on the horizon.
    Waters AM; Licht C
    Pediatr Nephrol; 2011 Jan; 26(1):41-57. PubMed ID: 20556434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
    Fremeaux-Bacchi V; Fakhouri F; Garnier A; Bienaimé F; Dragon-Durey MA; Ngo S; Moulin B; Servais A; Provot F; Rostaing L; Burtey S; Niaudet P; Deschênes G; Lebranchu Y; Zuber J; Loirat C
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):554-62. PubMed ID: 23307876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
    Frémeaux-Bacchi V; Miller EC; Liszewski MK; Strain L; Blouin J; Brown AL; Moghal N; Kaplan BS; Weiss RA; Lhotta K; Kapur G; Mattoo T; Nivet H; Wong W; Gie S; Hurault de Ligny B; Fischbach M; Gupta R; Hauhart R; Meunier V; Loirat C; Dragon-Durey MA; Fridman WH; Janssen BJ; Goodship TH; Atkinson JP
    Blood; 2008 Dec; 112(13):4948-52. PubMed ID: 18796626
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.